These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16614274)

  • 21. Economic evaluation of a general practitioner with special interests led dermatology service in primary care.
    Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C
    BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients.
    Offord R; Lloyd AC; Anderson P; Bearne A
    Pharm World Sci; 2004 Aug; 26(4):214-20. PubMed ID: 15446778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain.
    Thomas KJ; MacPherson H; Ratcliffe J; Thorpe L; Brazier J; Campbell M; Fitter M; Roman M; Walters S; Nicholl JP
    Health Technol Assess; 2005 Aug; 9(32):iii-iv, ix-x, 1-109. PubMed ID: 16095547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of oral nicorandil in patients with end-stage renal disease: a retrospective chart review after coronary angioplasty in Japanese patients receiving hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Yamada S; Kasuga H; Ichimiya S; Kanashiro M; Mitsuhashi H; Maruyama S; Matsuo S; Naruse K; Matsubara T; Murohara T
    Clin Ther; 2007 Jan; 29(1):110-22. PubMed ID: 17379051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina.
    Henderson RA; Pocock SJ; Sharp SJ; Nanchahal K; Sculpher MJ; Buxton MJ; Hampton JR
    Lancet; 1998 Oct; 352(9138):1419-25. PubMed ID: 9807988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost effectiveness of eptifibatide in acute coronary syndromes; an economic analysis of Western European patients enrolled in the PURSUIT trial. The Platelet IIa/IIb in unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Brown RE; Henderson RA; Koster D; Hutton J; Simoons ML
    Eur Heart J; 2002 Jan; 23(1):50-8. PubMed ID: 11741362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
    Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
    [No Abstract]   [Full Text] [Related]  

  • 30. Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer.
    Billingham LJ; Bathers S; Burton A; Bryan S; Cullen MH
    Lung Cancer; 2002 Aug; 37(2):219-25. PubMed ID: 12140146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term use of oral nicorandil stabilizes coronary plaque in patients with stable angina pectoris.
    Izumiya Y; Kojima S; Kojima S; Araki S; Usuku H; Matsubara J; Sakamoto K; Tsujita K; Nagayoshi Y; Kaikita K; Sugiyama S; Ogawa H
    Atherosclerosis; 2011 Feb; 214(2):415-21. PubMed ID: 21168844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
    Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
    Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis.
    Edwards RT; Céilleachair A; Bywater T; Hughes DA; Hutchings J
    BMJ; 2007 Mar; 334(7595):682. PubMed ID: 17350965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial.
    Weintraub WS; Mahoney EM; Zhang Z; Chu H; Hutton J; Buxton M; Booth J; Nugara F; Stables RH; Dooley P; Collinson J; Stuteville M; Delahunty N; Wright A; Flather MD; De Cock E
    Heart; 2004 Jul; 90(7):782-8. PubMed ID: 15201249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.
    Connock M; Burls A; Frew E; Fry-Smith A; Juarez-Garcia A; McCabe C; Wailoo A; Abrams K; Cooper N; Sutton A; O'Hagan A; Moore D
    Health Technol Assess; 2006 Jul; 10(24):iii-iv, ix-136. PubMed ID: 16796930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costs of coronary heart disease and stroke: the case of Sweden.
    Zethraeus N; Molin T; Henriksson P; Jönsson B
    J Intern Med; 1999 Aug; 246(2):151-9. PubMed ID: 10447784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis.
    Taylor RS; Watt A; Dalal HM; Evans PH; Campbell JL; Read KL; Mourant AJ; Wingham J; Thompson DR; Pereira Gray DJ
    Int J Cardiol; 2007 Jul; 119(2):196-201. PubMed ID: 17084927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the outcomes of the prolonged antianginal therapy use in stable coronary artery disease patients according to the data of randomized and observational studies.
    Martsevich SY; Lukina YV; Kutishenko NP; Semenova YV
    Contemp Clin Trials Commun; 2021 Mar; 21():100743. PubMed ID: 33665472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.
    Mihaylova B; Briggs A; Armitage J; Parish S; Gray A; Collins R;
    Lancet; 2005 May 21-27; 365(9473):1779-85. PubMed ID: 15910950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.